Literature DB >> 16212404

Data-dependent electron capture dissociation FT-ICR mass spectrometry for proteomic analyses.

Helen J Cooper1, Shiva Akbarzadeh, John K Heath, Martin Zeller.   

Abstract

Electron capture dissociation (ECD) offers many benefits for the analysis of peptides and proteins, and consequently shows great potential for the field of proteomics. Recent developments have reduced the time scale required for ECD to milliseconds resulting in the technique's compatibility with on-line separation techniques, e.g., HPLC. Here, we demonstrate incorporation of ECD into a high-throughput data-dependent LC-MS/MS approach for the analysis of proteomic samples. The approach is applied to analysis of the protein Fc-ROR2 isolated from chondrocytes and is the first example of LC-ECD-MS/MS of such a sample. Protein sequence coverage was 29%. Within that coverage, fifteen peptides were isolated and subjected to ECD. In most cases, the sequence tag generated by ECD was over 70% (in terms of the number of peptide backbone cleavages). The ECD data were searched against the nonredundant human NCBI database using the SEQUEST algorithm. Protein ROR2 was assigned, as was IgG (Fc domain). The results demonstrate the suitability of ECD as an integral technique in high-throughput proteomic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212404     DOI: 10.1021/pr050090c

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  Defining intact protein primary structures from saliva: a step toward the human proteome project.

Authors:  F Halgand; V Zabrouskov; S Bassilian; P Souda; J A Loo; K F Faull; D T Wong; J P Whitelegge
Journal:  Anal Chem       Date:  2012-05-02       Impact factor: 6.986

2.  Periodic sequence distribution of product ion abundances in electron capture dissociation of amphipathic peptides and proteins.

Authors:  Hisham Ben Hamidane; Huan He; Oleg Yu Tsybin; Mark R Emmett; Christopher L Hendrickson; Alan G Marshall; Yury O Tsybin
Journal:  J Am Soc Mass Spectrom       Date:  2009-02-13       Impact factor: 3.109

3.  What does the future hold for Top Down mass spectrometry?

Authors:  Benjamin A Garcia
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

Review 4.  Protein analysis by shotgun/bottom-up proteomics.

Authors:  Yaoyang Zhang; Bryan R Fonslow; Bing Shan; Moon-Chang Baek; John R Yates
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

5.  Characterization of 4-hydroxy-2-nonenal-modified peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: neutral loss-driven MS3 versus neutral loss-driven electron capture dissociation.

Authors:  Navin Rauniyar; Stanley M Stevens; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

6.  Novel glycosylation sites localized in Campylobacter jejuni flagellin FlaA by liquid chromatography electron capture dissociation tandem mass spectrometry.

Authors:  Cleidiane G Zampronio; Gemma Blackwell; Charles W Penn; Helen J Cooper
Journal:  J Proteome Res       Date:  2011-02-03       Impact factor: 4.466

7.  Liquid chromatography electron capture dissociation tandem mass spectrometry (LC-ECD-MS/MS) versus liquid chromatography collision-induced dissociation tandem mass spectrometry (LC-CID-MS/MS) for the identification of proteins.

Authors:  Andrew J Creese; Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-09       Impact factor: 3.109

8.  The effect of phosphorylation on the electron capture dissociation of peptide ions.

Authors:  Andrew J Creese; Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2008-05-28       Impact factor: 3.109

9.  Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.

Authors:  Steve M M Sweet; Christopher M Bailey; Debbie L Cunningham; John K Heath; Helen J Cooper
Journal:  Mol Cell Proteomics       Date:  2009-01-08       Impact factor: 5.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.